ICU Medical (NASDAQ:ICUI) reported third-quarter revenue of $556 million and said it expects full-year adjusted earnings to finish toward the high end of its existing guidance, as growth in infusion products and improved margins offset a decline in Vital Care. Revenue rose 4% on a reported basis and 5% organically. Adjusted earnings per share increased […]

ICU Medical (NASDAQ:ICUI) reported third-quarter revenue of $556 million and said it expects full-year adjusted earnings to finish toward the high end of its existing guidance, as growth in infusion products and improved margins offset a decline in Vital Care. Revenue rose 4% on a reported basis and 5% organically. Adjusted earnings per share increased […]